Literature DB >> 7909244

Loss of heterozygosity of the thyroid hormone receptor B in posterior uveal melanoma.

K Sisley1, D Curtis, I G Rennie, R C Rees.   

Abstract

Cytogenetic investigations of posterior uveal melanomas have identified non-random changes of chromosomes 3, 6, and 8. Monosomy of chromosome 3 with additional copies of 8q occur principally in the subgroup of uveal melanomas arising from the ciliary body. To determine whether ciliary body and choroidal melanomas maintain submicroscopic differences in their genetic aetiology, studies of the loss of heterozygosity (LOH) of THRB (ERBA beta) on 3p were undertaken. DNA from the blood and tumours of 19 patients with uveal melanoma were analysed for LOH of two restriction fragment length polymorphisms (RFLP). Approximately 60% of the uveal melanomas demonstrated allelic loss of THRB. Although the majority of tumours with allelic loss originated wholly, or in part, from the ciliary body, choroidal melanomas also demonstrated allelic loss of THRB. These results suggest that deletions of chromosome 3 occur in the absence of visible cytogenetic changes and may imply that alterations of chromosome 3 are integral to the tumourigenesis of both sets of uveal melanomas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7909244     DOI: 10.1097/00008390-199311000-00009

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  16 in total

Review 1.  Thyroid hormone receptors and cancer.

Authors:  Won Gu Kim; Sheue-yann Cheng
Journal:  Biochim Biophys Acta       Date:  2012-04-06

2.  Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs.

Authors:  I H Chan; M L Privalsky
Journal:  Oncogene       Date:  2006-01-23       Impact factor: 9.867

3.  Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression.

Authors:  F Rosignolo; V Maggisano; M Sponziello; M Celano; C R T Di Gioia; M D'Agostino; L Giacomelli; A Verrienti; M Dima; V Pecce; C Durante
Journal:  J Endocrinol Invest       Date:  2015-05-24       Impact factor: 4.256

Review 4.  The genetics of uveal melanoma: an emerging framework for targeted therapy.

Authors:  J William Harbour
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

Review 5.  Genetic features of thyroid hormone receptors.

Authors:  Maha Rebaï; Imen Kallel; Ahmed Rebaï
Journal:  J Genet       Date:  2012       Impact factor: 1.166

Review 6.  Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesis.

Authors:  Stephen Hyter; Arup K Indra
Journal:  FEBS Lett       Date:  2013-02-05       Impact factor: 4.124

7.  Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.

Authors:  Won Gu Kim; Li Zhao; Dong Wook Kim; Mark C Willingham; Sheue-yann Cheng
Journal:  Thyroid       Date:  2013-09-04       Impact factor: 6.568

8.  Analysis of Thyroid Tumorigenesis in Xenograft Mouse Model.

Authors:  Xuguang Zhu; Sheue-Yann Cheng
Journal:  Methods Mol Biol       Date:  2018

9.  Inhibition of estrogen-dependent tumorigenesis by the thyroid hormone receptor β in xenograft models.

Authors:  Jeong Won Park; Li Zhao; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2013-06-20       Impact factor: 6.166

10.  Thyroid hormone receptor β suppresses SV40-mediated tumorigenesis via novel nongenomic actions.

Authors:  Dong Wook Kim; Li Zhao; John Hanover; Mark Willingham; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2012-08-23       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.